Peak Bio
Palo Alto
About Peak Bio
Peak Bio is a Biopharmaceutical company that focuses on the drug development to treat Oncology and Inflammatory diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $25.0M
- Funding stage: M&A
- Last round: Post-IPO Equity (Apr 2022)
- Ticker: otcqb:PKBO
- Website: peak-bio.com
- Phone: +1-650-549-9103
Industries & Categories
Biopharma, Biotechnology, Oncology
Social Profiles
Canonical: https://fsome.com/organization/peak-bio-139341 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.